Stratification of ST-elevation myocardial infarction patients based on soluble CD40L longitudinal changes
- 1 October 2016
- journal article
- Published by Elsevier in Translational Research
- Vol. 176, 95-104
Abstract
No abstract availableKeywords
Funding Information
- Fundação para a Ciência e Tecnologia (SFRM/BPD/6308/2009, UID/BIO/04565/2013)
- Liga dos Amigos do Hospital de Santa Marta
This publication has 41 references indexed in Scilit:
- Changes of soluble CD40 ligand in the progression of acute myocardial infarction associate to endothelial nitric oxide synthase polymorphisms and vascular endothelial growth factor but not to platelet CD62P expressionTranslational Research, 2015
- The CD40/CD40L system: A new therapeutic target for diseaseImmunology Letters, 2013
- Binding of CD40L to Mac-1's I-Domain Involves the EQLKKSKTL Motif and Mediates Leukocyte Recruitment and Atherosclerosis—But Does Not Affect Immunity and Thrombosis in MiceCirculation Research, 2011
- CD40–CD40 ligand interactions in oxidative stress, inflammation and vascular diseaseTrends in Molecular Medicine, 2008
- Soluble CD40 ligand induces endothelial dysfunction in human and porcine coronary artery endothelial cellsBlood, 2008
- Comparative Impact of Multiple Biomarkers and N-Terminal Pro-Brain Natriuretic Peptide in the Context of Conventional Risk Factors for the Prediction of Recurrent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) StudyCirculation, 2006
- Effect of Atorvastatin on Risk of Recurrent Cardiovascular Events After an Acute Coronary Syndrome Associated With High Soluble CD40 Ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) StudyCirculation, 2004
- Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerizationJACC, 2004
- Soluble CD40LCirculation, 2003
- Enhanced Levels of Soluble and Membrane-Bound CD40 Ligand in Patients With Unstable AnginaCirculation, 1999